title: Embryo extracts opotherapy reduces alpha-fetoprotein levels in hepatocellular carcinoma patients.
authors.forename: Fabrizió
authors.initials: F
authors.lastname: Franchi
authors.forename: Tommaso
authors.initials: T
authors.lastname: Ielapi
authors.forename: Mariano
authors.initials: M
authors.lastname: Bizzarri
authors.forename: Patrizia
authors.initials: P
authors.lastname: Seminara
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000188:drug therapy*; D004622:Embryo, Mammalian; D004625:Embryo, Nonmammalian; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000188:drug therapy*; D014020:Tissue Extracts / Q000627:therapeutic use*; D015027:Zebrafish; D000509:alpha-Fetoproteins / Q000032:analysis*
chemical_list: D000970:Antineoplastic Agents; D014020:Tissue Extracts; D000509:alpha-Fetoproteins